Inflammasome activation contributes to interleukin-23 production in response to Clostridium difficile

mBio

Volumn 6, Issue 1, 2015, Pages

  Cowardin, Carrie A ^a   Kuehne, Sarah A ^b   Buonomo, Erica L ^a   Marie, Chelsea S ^c   Minton, Nigel P ^b   Petri, William A ^a,c  

^a UNIVERSITY OF VIRGINIA   (United States)

^b UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^c UNIVERSITY OF VIRGINIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLOSTRIDIUM DIFFICILE TOXIN A; CLOSTRIDIUM DIFFICILE TOXIN B; DAMAGE ASSOCIATED MOLECULAR PATTERN; INFLAMMASOME; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 1BETA; INTERLEUKIN 23; MESSENGER RNA; MICROBIAL PRODUCTS NOT CLASSIFIED ELSEWHERE; MYELOID DIFFERENTIATION FACTOR 88; PATHOGEN ASSOCIATED MOLECULAR PATTERN; PATTERN RECOGNITION RECEPTOR; POTASSIUM; UNCLASSIFIED DRUG; BACTERIAL PROTEIN; BACTERIAL TOXIN; ENTEROTOXIN; TCDA PROTEIN, CLOSTRIDIUM DIFFICILE; TOXB PROTEIN, CLOSTRIDIUM DIFFICILE;

ANALYTICAL PARAMETERS; ANIMAL CELL; ARTICLE; CLOSTRIDIUM DIFFICILE INFECTION; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DENDRITIC CELL; EXTRACELLULAR POTASSIUM; HUMAN; HUMAN CELL; IMMUNE RESPONSE; MAJOR CLINICAL STUDY; MALE; MOUSE; NONHUMAN; PATHOGENESIS; PEPTOCLOSTRIDIUM DIFFICILE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; CLOSTRIDIUM INFECTION; GENETICS; IMMUNOLOGY; MICROBIOLOGY; PHYSIOLOGY;

BACTERIA (MICROORGANISMS); CLOSTRIDIUM DIFFICILE;

BACTERIAL PROTEINS; BACTERIAL TOXINS; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM INFECTIONS; DENDRITIC CELLS; ENTEROTOXINS; HUMANS; INFLAMMASOMES; INTERLEUKIN-1BETA; INTERLEUKIN-23;

EID: 84924181912     PISSN: 21612129     EISSN: 21507511     Source Type: Journal    
DOI: 10.1128/mBio.02386-14     Document Type: Article

References (39)

1. Miller BA, Chen LF, Sexton DJ, Anderson DJ. 2011. Comparison of the burdens of hospital-onset, healthcare facility-associated Clostridium difficile infection and of healthcare-associated infection due to methicillinresistant Staphylococcus aureus in community hospitals. Infect Control Hosp Epidemiol 32: 387-390. http://dx. doi. org/10. 1086/659156.
2. Ananthakrishnan AN. 2011. Clostridium difficile infection: epidemiology, risk factors and management. Nat Rev Gastroenterol Hepatol 8: 17-26. http://dx. doi. org/10. 1038/nrgastro. 2010. 190.
3. Bacci S, Mølbak K, Kjeldsen MK, Olsen KE. 2011. Binary toxin and death after Clostridium difficile infection. Emerg Infect Dis 17: 976-982. http://dx. doi. org/10. 3201/eid/1706. 101483.
4. Bartlett JG, Chang TW, Gurwith M, Gorbach SL, Onderdonk AB. 1978. Antibiotic-associated pseudomembranous colitis due to toxin-producing clostridia. N Engl J Med 298: 531-534. http://dx. doi. org/10. 1056/NEJM197803092981003.
5. Buffie CG, Pamer EG. 2013. Microbiota-mediated colonization resistance against intestinal pathogens. Nat Rev Immunol 13: 790-801. http://dx. doi. org/10. 1038/nri3535.
6. Just I, Selzer J, Wilm M, von Eichel-Streiber C, Mann M, Aktories K. 1995. Glucosylation of Rho proteins by Clostridium difficile toxin B. Nature 375: 500-503. http://dx. doi. org/10. 1038/375500a0.
7. Chaves-Olarte E, Weidmann M, Eichel-Streiber C, Thelestam M. 1997. Toxins A and B from Clostridium difficile differ with respect to enzymatic potencies, cellular substrate specificities, and surface binding to cultured cells. J Clin Invest 100: 1734-1741. http://dx. doi. org/10. 1172/JCI119698.
8. Jefferson KK, Smith MF, Jr, Bobak DA. 1999. Roles of intracellular calcium and NF-αB in the Clostridium difficile toxin A-induced upregulation and secretion of IL-8 from human monocytes. J Immunol 163: 5183-5191.
9. Lee JY, Kim H, Cha MY, Park HG, Kim Y-J, Kim IY, Kim JM. 2009. Clostridium difficile toxin A promotes dendritic cell maturation and chemokine CXCL2 expression through p38, IKK, and the NF-kappaB signaling pathway. J Mol Med 87: 169-180. http://dx. doi. org/10. 1007/s00109-008-0415-2.
10. Xu H, Yang J, Gao W, Li L, Li P, Zhang L, Gong Y-N, Peng X, Xi JJ, Chen S, Wang F, Shao F. 2014. Innate immune sensing of bacterial modifications of Rho GTPases by the pyrin inflammasome. Nature 513: 237-241. http://dx. doi. org/10. 1038/nature13449.
11. Jafari NV, Kuehne SA, Bryant CE, Elawad M, Wren BW, Minton NP, Allan E, Bajaj-Elliott M. 2013. Clostridium difficile modulates host innate immunity via toxin-independent and dependent mechanism(s). PLoS One 8: e69846. http://dx. doi. org/10. 1371/journal. pone. 0069846.
12. Ng J, Hirota SA, Gross O, Li Y, Ulke-Lemee A, Potentier MS, Schenck LP, Vilaysane A, Seamone ME, Feng H, Armstrong GD, Tschopp J, Macdonald JA, Muruve DA, Beck PL. 2010. Clostridium difficile toxininduced inflammation and intestinal injury are mediated by the inflammasome. Gastroenterology 139: 542-552. http://dx. doi. org/10. 1053/j. gastro. 2010. 04. 005.
13. Ryan A, Lynch M, Smith SM, Amu S, Nel HJ, McCoy CE, Dowling JK, Draper E, O'Reilly V, McCarthy C, O'Brien J, Ní Eidhin D, O'Connell MJ, Keogh B, Morton, CO, Rogers TR, Fallon PG, O'Neill LA, Kelleher D, Loscher CE. 2011. A role for TLR4 in Clostridium difficile infection and the recognition of surface layer proteins. PLoS Pathog 7: e1002076. http://dx. doi. org/10. 1371/journal. ppat. 1002076.
14. Yoshino Y, Kitazawa T, Ikeda M, Tatsuno K, Yanagimoto S, Okugawa S, Yotsuyanagi H, Ota Y. 2013. Clostridium difficile flagellin stimulates Toll-like receptor 5, and toxin B promotes flagellin-induced chemokine production via TLR5. Life Sci 92: 211-217. http://dx. doi. org/10. 1016/j. lfs. 2012. 11. 017.
15. Hasegawa M, Yamazaki T, Kamada N, Tawaratsumida K, Kim Y-G, Núñez G, Inohara N. 2011. Nucleotide-binding oligomerization domain 1 mediates recognition of Clostridium difficile and induces neutrophil recruitment and protection against the pathogen. J Immunol 186: 4872-4880. http://dx. doi. org/10. 4049/jimmunol. 1003761.
16. Jarchum I, Liu M, Shi C, Equinda M, Pamer EG. 2012. Critical role for MyD88-mediated neutrophil recruitment during Clostridium difficile colitis. Infect Immun 80: 2989-2996. http://dx. doi. org/10. 1128/IAI. 00448-12.
17. Hasegawa M, Kamada N, Jiao Y, Liu MZ, Núñez G, Inohara N. 2012. Protective role of commensals against Clostridium difficile infection via an IL-1mediated positive-feedback loop. J Immunol 189: 3085-3091. http://dx. doi. org/10. 4049/jimmunol. 1200821.
18. El Feghaly R, Stauber JL, Deych E, Gonzalez C, Tarr PI, Haslam DB. 2013. Markers of intestinal inflammation, not bacterial burden, correlate with clinical outcomes in Clostridium difficile infection. Clin Infect Dis 56: 1713-1721. http://dx. doi. org/10. 1093/cid/cit147.
19. Buonomo EL, Madan R, Pramoonjago P, Li L, Okusa MD, Petri WA. 2013. Role of IL-23 signaling in Clostridium difficile colitis. J infect Dis 208: 917-920. http://dx. doi. org/10. 1093/infdis/jit277.
20. Liu W, Ouyang X, Yang J, Liu J, Li Q, Gu Y, Fukata M, Lin T, He JC, Abreu M, Unkeless JC, Mayer L, Xiong H. 2009. AP-1 activated by Toll-like receptors regulates expression of IL-23 p19. J Biol Chem 284: 24006-24016. http://dx. doi. org/10. 1074/jbc. M109. 025528.
21. Stabler RA, He M, Dawson L, Martin M, Valiente E, Corton C, Lawley TD, Sebaihia M, Quail MA, Rose G, Gerding DN, Gibert M, Popoff MR, Parkhill J, Dougan G, Wren BW. 2009. Comparative genome and phenotypic analysis of Clostridium difficile 027 strains provides insight into the evolution of a hypervirulent bacterium. Genome Biol 10: R102. http://dx. doi. org/10. 1186/gb-2009-10-9-r102.
22. Steele J, Chen K, Sun X, Zhang Y, Wang H, Tzipori S, Feng H. 2012. Systemic dissemination of Clostridium difficile toxins A and B is associated with severe, fatal disease in animal models. J Infect Dis 205: 384-391. http://dx. doi. org/10. 1093/infdis/jir748.
23. Eckhardt ER, Witta J, Zhong J, Arsenescu R, Arsenescu V, Wang Y, Ghoshal S, de Beer MC, de Beer FC, de Villiers WJ. 2010. Intestinal epithelial serum amyloid A modulates bacterial growth in Vitro and proinflammatory responses in mouse experimental colitis. BMC Gastroenterol 10: 133. http://dx. doi. org/10. 1186/1471-230X-10-133.
24. Von Moltke J, Ayres JS, Kofoed EM, Chavarría-Smith J, Vance RE. 2013. Recognition of bacteria by inflammasomes. Annu Rev Immunol 31: 73-106. http://dx. doi. org/10. 1146/annurev-immunol-032712-095944.
25. Peral de Castro C, Jones SA, Ní Cheallaigh C, Hearnden CA, Williams L, Winter J, Lavelle EC, Mills KH, Harris J. 2012. Autophagy regulates IL-23 secretion and innate T cell responses through effects on IL-1 secretion. J Immunol 189: 4144-4153. http://dx. doi. org/10. 4049/jimmunol. 1201946.
26. Akira S, Takeda K. 2004. Toll-like receptor signalling. Nat Rev Immunol 4: 499-511. http://dx. doi. org/10. 1038/nri1391.
27. + efflux is the common trigger of Nlrp3 inflammasome activation by bacterial toxins and particulate matter. Immunity 38: 1142-1153. http://dx. doi. org/10. 1016/j. immuni. 2013. 05. 016.
28. Chumbler NM, Farrow MA, Lapierre LA, Franklin JL, Haslam DB, Goldenring JR, Haslam D, Lacy DB. 2012. Clostridium difficile toxin B causes epithelial cell necrosis through an autoprocessing-independent mechanism. PLoS Pathog 8: e1003072. http://dx. doi. org/10. 1371/journal. ppat. 1003072.
29. Kuehne SA, Collery MM, Kelly ML, Cartman ST, Cockayne A, Minton NP. 2013. The importance of toxin A, toxin B and CDT in virulence of an epidemic Clostridium difficile strain. J Infect Dis 209: 83-86. http://dx. doi. org/10. 1093/infdis/jlt426.
30. Kuehne SA, Cartman ST, Heap JT, Kelly ML, Cockayne A, Minton NP. 2010. The role of toxin A and toxin B in Clostridium difficile infection. Nature 467: 711-713. http://dx. doi. org/10. 1038/nature09397.
31. Deakin LJ, Clare S, Fagan RP, Dawson LF, Pickard DJ, West MR, Wren BW, Fairweather NF, Dougan G, Lawley TD. 2012. The Clostridium difficile spo0a gene is a persistence and transmission factor. Infect Immun 80: 2704-2711. http://dx. doi. org/10. 1128/IAI. 00147-12.
32. Pawlowski SW, Calabrese G, Kolling GL, Freire R, AlcantaraWarren C, Liu B, Sartor RB, Guerrant RL. 2010. Murine model of Clostridium difficile infection with aged gnotobiotic C57BL/6 mice and a BI/NAP1 strain. J Infect Dis 202: 1708-1712. http://dx. doi. org/10. 1086/657086.
33. Steiner TS, Flores CA, Pizarro TT, Guerrant RL. 1997. Fecal lactoferrin, interleukin-1beta, and interleukin-8 are elevated in patients with severe Clostridium difficile colitis. Clin Diagn Lab Immunol 4: 719-722.
34. Zhang X, Cheng Y, Xiong Y, Ye C, Zheng H, Sun H, Zhao H, Ren Z, Xu J. 2012. Enterohemorrhagic Escherichia coli specific enterohemolysin induced IL-1+ in human macrophages and EHEC-induced IL-1+ required activation of Nlrp3 inflammasome. PLoS One 7: e50288. http://dx. doi. org/10. 1371/journal. pone. 0050288.
35. Stevens C, Walz G, Singaram C, Lipman ML, Zanker B, Muggia A, Antonioli D, Peppercorn MA, Strom TB. 1992. Tumor necrosis factoralpha, interleukin-1beta, and interleukin-6 expression in inflammatory bowel disease. Dig Dis Sci 37: 818-826. http://dx. doi. org/10. 1007/BF01300378.
36. Kelly CP, Becker S, Linevsky JK, Joshi MA, O'Keane JC, Dickey BF, LaMont JT, Pothoulakis C. 1994. Neutrophil recruitment in Clostridium difficile toxin A enteritis in the rabbit. J Clin Invest 93: 1257-1265. http://dx. doi. org/10. 1172/JCI117080.
37. Cartman ST, Minton NP. 2010. A Mariner-based transposon system for in vivo random mutagenesis of Clostridium difficile. Appl Environ Microbiol 76: 1103-1109. http://dx. doi. org/10. 1128/AEM. 02525-09.
38. Gross O. 2012. Measuring the inflammasome. Methods Mol Biol 844: 199-222. http://dx. doi. org/10. 1007/978-1-61779-527-5_15.
39. Tedder TF, Jansen PJ. 2001. Isolation and generation of human dendritic cells. Curr Protoc Immunol Chepter 7: Unit 7. 32. http://dx. doi. org/10. 1002/0471142735. im0732s23.